Sarah Gasper, BEVA’S Learning Manager said: "Many of us on the BEVA education team understand exactly what it’s like to return to practice whether after a career break, paternity/maternity or sickness leave. We also understand the specific challenges of moving from mixed into equine practice.
"We have created these courses to help make the transition back to work as smooth as possible. We’ve tried to incorporate everything we wish we had had access to when we returned to practice!"
Reinvigorate your approach to equine practice will be held on 12th March 2019 at Lythe Hill Hotel, Haslemere. The lecture and forum based course will explore the latest advances in internal medicine, orthopaedics, and sports medicine, and how to apply them to develop evidence-based clinical approaches to common and emergency scenarios in practice.
Getting (back) into equine practice will be held on 13th March 2019 at Liphook Equine Hospital, Hampshire. This entirely practical day of CPD will all be about improving the confidence of established equine vets and for vets returning to work following a career break. The course will focus on the practical procedures that an established equine ambulatory vet might be expected to perform on a regular basis. In a new approach to CPD we are trialling a system where delegates can shape part of this unique CPD day for themselves, with an online poll pre-course to select from a choice of practicals.
Both courses will have childcare facilities to help support parents wishing to attend CPD.
BEVA will also be running a course on the fundamentals of sedation, field anaesthesia and castration on 27th and 28th March 2019 at World Horse Welfare, Snetterton, Norfolk. This 'hands-on' course is designed for new or recent graduates or those in mixed practice with varied levels of equine work. It comprises evening lectures on the first day to free up more time for hands-on training on day two. It will cover sedation and field anaesthesia required for common field surgery such as castration, both in theory and in a practical session, with the equine welfare charity venue able to provide a high number of colts for castration work. Nerve blocks and regional anaesthesia for other common procedures will also be covered on cadavers.
For further information on BEVA’s new CPD courses visit www.beva.org.uk/cpd
IVC says this means its UK practices are on track to hit a group target of 5% by 2030, which follows in the footsteps of other IVC Evidensia territories such as Sweden and Norway, which have already reached figures of 4.9% and 5.9% respectively.
To achieve this progress, IVC says it has implemented a number of initiatives:
IVC says there has been a concerted efforts by its vets to become more aware of their own attitudes towards antibiotics and to educate their clients about the dangers of AMR.
One such example is Angharad Thomas, a veterinary surgeon from Fivelands Veterinary Centre in the West Midlands, who managed to reduce the amount of antibiotics prescribed in dentistry by 17.8% between 2022 and 2023:
She said: “Long dental treatments are a great time to chat to vet students, but one day, instead of quizzing them, I was trotting out my thoughts on the decision-making for the case when I reached post-operative drugs.
"Stopping here I asked: ‘What are you taught about this these days?’
"I suppose I wasn’t surprised to hear that antibiotics didn’t feature.
“It was a lightbulb moment: Why was I using post-operative antibiotics for my dental cases?
"I come from the generation of vets who were firmly taught never to give antibiotics to routine surgeries, so why was I continuing to use antibiotics in dentistry?
"All at once I felt terribly old and out-of-touch. I decided it was time for a change!”
“Given that reducing antibiotic usage is now fairly well recognised by the general public, owners have appeared very supportive.
"A day three post-operative check provides reassurance that their pet is healing and allows us an opportunity to intervene if required.”
“Being an ‘experienced’ vet can be a trade-off between textbook clinical decision-making and what we believe would work for our patients and their owners.
"Sometimes we need a paper or two to persuade us to change our ways, but here, going back to basic principles was enough for me.
“Twelve months later, after watching my cases for any mild complications and reflecting on the whether such complications could be attributed to the lack of antibiotics, I am convinced that this change has had no negative effects on my patients.”
https://ivcevidensia.co.uk/positive-pawprint
The study was part of a research project called VetCompass, through which the RVC, in collaboration with Vets Now, collects anonymised clinical information on over 6 million companion animals under veterinary care in the UK.
The study investigated bitches presented with difficulty giving birth (dystocia) from among almost 20,000 bitches attending 50 Vets Now surgeries. Researchers found that out of 20,000 bitches receiving emergency veterinary care, 3.7 per cent of these were treated because of difficulties encountered giving birth.
The most commonly affected breeds were the French Bulldog (15.9 times more likely), Boston Terrier (12.9 times more likely), Chihuahua (10.4 times more likely) and Pug (11.3 times more likely).
Dr Dan O’Neill, a companion animal epidemiologist within the VetCompass Programme, said: "Giving birth in dogs is not always a benign process and our research shows this risk is especially exacerbated in some common brachycephalic and toy breeds. Prospective owners should bear these welfare costs for high risk breeds in mind when choosing their new puppy."
Caroline Kisko, Kennel Club Secretary, said: 'VetCompass' research will not only enable dog breeders to make responsible breeding choices to improve the health of these dogs, it will help to highlight what puppy buyers need to be looking out for if they are intent on owning one of these breeds. If people are choosing a breed simply for its looks and are not going to a reputable breeder, they are likely to face high vet costs and a lifetime of heartache."
This study builds on previous 'purchasing' research by the RVC which found that appearance is the number one reason why owners purchase flat-faced breeds, even though their large, round, wide-set eyes, and flat rounded faces are linked with a variety of inherited diseases.
Dr Rowena Packer, lead author of the study and Research Fellow at RVC, said: "Potential puppy buyers attracted to the appearance of these breeds should seriously consider whether they are emotionally and financially prepared to take on a breed with high risks of health complications, and consider whether alternative, lower-risk breeds would better fit their lifestyle."
Firstly, the BVA recommends that more work needs to be done in order to clarify and communicate the duties that can already be delegated to Registered Veterinary Nurses under Schedule 3.
In addition, the Association says that:
there should be an expanded role for RVNs in general anaesthesia, where the veterinary surgeon maintains overall responsibility
consideration should be given to granting RVNs expanded rights to dispense POM-V flea and worming treatments
consideration should be given to expanding the role of RVNs in the management of chronic cases, including repeat dispensing
consideration should be given to the potential role for RVNs in dispensing contraceptives, anthelmintics and vaccines in a zoo setting
it would be beneficial to incorporate the Suitably Qualified Person (SQP) role within RVN training
The BVA also recommends that there should be accessible, flexible and professionally recordable post-registration awards for RVNs from all academic backgrounds, and has reiterated its call for the protection of the title of 'Veterinary Nurse.'
BVNA Junior Vice President Jo Hinde RVN (pictured right) said: "BVNA strongly supports the vet-led approach as we believe working together as a team is the best way to improve both patient and staff welfare. We are delighted to be working on this project with BVA and are using our best efforts to continue to strive to strengthen the role of the RVN.
"We have always believed the VN title needs to be protected and this is increasingly important as the veterinary profession adapts to new challenges. It is vital that owners can be confident that their pet is being looked after by well-trained and RCVS-registered staff, as well as there being more clarity surrounding Schedule 3 procedures.
"The support for the advancement of the nursing role through post-registration qualifications is a welcome development and we believe this will help enable RVNs to follow their passion for a particular subject and allow them to significantly increase their knowledge in specific areas of interest. When following the vet-led model, this would result in a strong team of individuals with in-depth knowledge that can enhance their patients’ care."
The double-blind placebo-controlled study will examine whether the pheromone collar can help reduce the severity or development of certain potentially problematic behaviours in puppies and it is open to puppies less than 12 weeks of age.
Puppies will have to wear a collar until they are six months of age and their owners will be asked to complete a check sheet relating to their puppy’s behaviour every month. Each month a new collar will be sent direct to their home.
To encourage enrolment, the University of Lincoln is offering veterinary professionals a £10 voucher for every successful sign up to the trial.
Owners who complete all questionnaires will receive a pack of canine health and welfare goodies from Ceva Animal Health. The pack will include Adaptil Junior, Adaptil Transport and Logic Oral Hygiene Gel.
Owners will also be entered into a draw to win an iPad.
A marketing pack is available to raise awareness of the study and includes a waiting room poster, owner leaflets and a social media post for Twitter, Facebook or Instagram.
For further information, email the University of Lincoln at puppydevelopment@lincoln.ac.uk.
Nebojsa Petrovic faced eight charges, although charge four was withdrawn at the start of the hearing.
At the outset of the hearing, Dr Petrovic admitted a number of allegations, including:
Charge 1 - that in November 2021, he falsely represented to the Animal and Plant Health Agency (APHA) that blood samples he submitted in respect of four horses were from the same horses as the samples he submitted on 1 November 2021.
Charge 2 – that in November 2021, he told APHA’s Veterinary Head of Border Control that he had checked the microchips and/or passports of the four horses when he hadn’t done so;
Charge 3 – that in November 2021, he signed Export Health Certificates for the four horses, in which it was stated that blood samples taken from these horses on October 2021 had been submitted to the Veterinary Laboratories Agency laboratory, Weybridge, with a negative result for Leptospirosis when in fact those samples had tested positive;
Charge 5 – that he failed to send the APHA’s Centre for International Trade, within seven days of signing, certified copies of the export health certificates;
Charge 7 – that in January 2022, he told an APHA officer that he was satisfied that he had properly identified the horses for which you had submitted the two samples when he had not done so;
Charge 8c – that he risked undermining government procedures designed to promote animal health and international relations in relation to the charges he admitted; and
Charge 9 – that in February 2022, he failed to have in place any or any adequate Professional Indemnity Insurance (PII).
Dr Petrovic, who was at the time of all the allegations carrying his duties as an Official Veterinarian on behalf of the APHA, denied charge 6 – that in November 2021, he failed to take sufficient steps to prevent the four horses being exported to Serbia, when he had been informed that there were concerns and/or doubts about whether those horses had tested negative for Leptospirosis.
He also denied charge 8 – that in relation to the allegations relating to his submitting the blood samples to the Veterinary Laboratories Agency on 8 November 2021, certification of the Export Health Certificates on 16 November 2021 and his subsequent conversations with members of APHA staff regarding both sets of documentation he had acted in a misleading (Charge 8a) and/or dishonest (Charge 8b) way.
The Committee considered evidence presented by the College including hearing from APHA staff witnesses called by the College and also hearing from a witness and character evidence presented by Dr Petrovic. Dr Petrovic also gave evidence to the Committee.
It found most charges proven with the exception of Charge 6, and also found that Dr Petrovic had not acted dishonestly in submitting the blood samples or certifying the EHC’s as alleged in charges 1 and 3.
The Committee concluded that Dr Petrovic had acted in a dishonest and misleading way in his conversations with the APHA staff as detailed in charges 2 and 7.
The Committee then considered whether the individual proven charges amounted to serious professional misconduct, determining that, with the exception of charges 3 and 5, all proven charges amounted to disgraceful conduct.
Paul Morris, chairing the Committee and speaking on its behalf, said: “In the Committee’s judgement, the respondent’s position as an Official Veterinarian also meant that he had a responsibility to ensure that the trust which was delegated to him was not breached.
"In his role, the respondent was acting in a position of trust, as a representative of the government, and the Committee found that he had breached that trust…. It took these matters into account when determining that the respondent’s behaviour cumulatively amounted to disgraceful conduct in a professional respect.”
Regarding the sanction for Dr Petrovic, the Committee considered his request that it consider suspension, rather than removal, from the Register.
In terms of aggravating factors – the Committee found that Dr Petrovic had acted without integrity, recklessly and without regard for the APHA’s systems relating to the export of animals.
In mitigation, it took into account: the fact that no animal was harmed by his conduct, albeit there was risk of harm; his long and unblemished career in the UK since 1994; admissions he had made to the APHA and Disciplinary Committee at the first day of the hearing; had remediated his lack of professional indemnity insurance by putting in place a retrospective policy; the significant amount of time that had elapsed since the conduct; and six positive character references from experienced fellow veterinary surgeons who held him in high regard.
Paul Morris added: “The Committee took into account that the respondent had continued to work as a veterinary surgeon with no subsequent complaints and that he had a previous long and unblemished record and there was support by several positive character references.
"The Committee also took into consideration the pressures of Brexit and the pandemic which the respondent had faced at the time, but which were unlikely to occur again.
“The Committee had concluded that the respondent was unlikely to repeat similar behaviour or to pose a risk to animals, particularly because he was no longer involved in certifying animals for export.
"Furthermore his admissions to most of the matters it had found proved showed that he had some insight.
"The Committee was also satisfied that the respondent had a genuine concern for the welfare of animals and it noted that the Respondent did not require any further training to continue in practice as a veterinary surgeon.
“The Committee therefore concluded that a suspension from the Register was the proportionate sanction in this case taking into account the seriousness of the conduct it had found proved but also all of the mitigating factors.”
The Committee recommended that Dr Petrovic be suspended for six months to reflect the seriousness of the conduct and the damage it could do to public confidence in the profession, while meeting the public interest and sending a clear message of deterrence.
www.rcvs.org.uk/disciplinary
Novartis Animal Health has announced that it will no longer be manufacturing and supplying the enzootic abortion vaccine, Mydiavac.
The company reassures its customers that current stocks will continue to be distributed as smoothly as possible.
Merial Animal Health has launched Veloxa, a palatable broad spectrum dewormer for dogs, effective against roundworm, hookworm, whipworm and tapeworm.
Merial says Veloxa uses a proprietary technology which coats the bitter active ingredients in the beef-flavoured chewable tablets. In the company's palatability tests it achieved 97% acceptance.
Veloxa tablets are scored for accurate dosing and come in two sizes:
Christine Male, Product Manager of Veloxa said: "Merial has a strong heritage in anti-parasitics and understands how difficult it can be for pet owners to administer worming tablets, so we are extremely pleased to be able to offer Veloxa as part of the Merial anti-parasitics range."
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.
Reference
The first, carried out by Nanna Luthersson and colleagues and published online in the Journal of Equine Veterinary Science in March, evaluated the laminitis risk factors in a group of Danish horses and ponies.1 It confirmed that Cold-blooded type animals <149cm, such as certain native ponies, as well as those being kept on high quality pasture were at an increased risk of developing laminitis for the first time. It also highlighted the important role that a change in grass intake, in terms of both type and amount, may play at any time of the year not only the spring as commonly thought.
The second study, funded in part by the PetPlan Charitable Trust, British Veterinary Association Animal Welfare Foundation Norman Hayward Fund and the Laminitis Trust, was undertaken in conjunction with Nicola Menzies-Gow (Royal Veterinary College) and published online in the Equine Veterinary Journal (EVJ) in August. The study evaluated the risk factors for the development of laminitis prior to the occurrence of the disease.2 It identified that low concentrations of the adipose tissue derived hormone adiponectin, together with high serum insulin concentrations (at rest and as part of a diagnostic test for PPID) may predict an increased risk of future pasture-associated laminitis.
It is hoped that future studies will be able to generate more robust cut off values, which will more accurately predict future laminitis development in an individual animal.
The RVC in collaboration with Waltham is now taking this forward through a study in which these markers are measured regularly, in conjunction with a detailed management assessment, in a group of ponies with no known history of laminitis at the start.
Clare Barfoot RNutr and the research and development manager at Spillers said: "The Danish study gives us important practical facts about the susceptibility of cold-blooded types, and is particularly applicable to natives in the UK. The second study gives hope that there may soon be a test or series of tests that will help predict those at an increased risk of suffering from pasture associated laminitis in the future thereby reducing the number of animals affected by this debilitating condition. In the meantime until we fully understand the condition it is sensible to manage all the risk factors we currently know about, in particular keeping your horse at a healthy weight."
References
The programme also introduces an extended nursing stream, focused on surgery and emergency and critical care nursing. In total, the conferences offer more than 27 hours of CPD each through the two veterinary streams, together with the two-day nursing stream.
VetsSouth takes place on 6-7 March, at Sandy Park in Exeter. VetsNorth takes place on 12-13 June at the AJ Bell Stadium in Manchester. Early-bird rates are now available for both events.
Speakers for 2019 include Ed Hall, Professor of Small Animal Internal Medicine at the University of Bristol, who will discuss pancreatitis in the dog; Dr Georgie Hollis, founder of Intelligent Wound Care, a company which aims to bring the best of modern wound care to veterinary practice and veterinary welfare campaigner and vet Emma Milne who will discuss welfare issues relating to brachycephalic animals.
An exhibition showcasing the latest veterinary products and services and featuring demonstrations and workshops from exhibitors will run alongside the conferences.
Matt Colvan, Event Director, said: "VetsSouth and VetsNorth have established themselves as friendly, relaxed conferences, offering high quality CPD for vets and vet nurses who may not be able to get easily to the larger veterinary events. We urge delegates to take advantage of our time-limited Early-bird offers and register without delay."
Ceva Animal Health has launched a new broad-spectrum, flavoured endoparasiticide tablet, Milbactor for dogs.
Milbactor contains milbemycin oxime and praziquantel, which offer protection against the common nematodes seen in the UK and the main species of tapeworm.
Milbemycin oxime treats Toxocara canis and Toxascaris leonina, Angiostrongylus vasorum and Crenosoma vulpis, the hookworm Ancylostoma caninum, the whipworm Trichuris vulpis and the eyeworm, Thelazia callipaeda. Milbactor also prevents heartworm disease caused by Dirofilaria immitis.
Praziquantel protects against Echinococcus spp., Dipylidium caninum, Taenia spp. and Mesocestoides spp.
Puppies weighing more than 0.5 kg can be treated with Milbactor from two weeks of age. Milbactor comes in two tablet sizes for dogs and puppies, and the tablets are flavoured for easy administration.
Ceva has also launched The Ceva Protection System for dogs, a two-step solution featuring Vectra 3D and Milbactor to provide ectoparasite and endoparasite protection for dogs with one monthly topical treatment and one flavoured tablet. The Ceva Protection System uses Vectra Felis for flea protection for cats and Acclaim for the treatment of the pet's home environment.
Rob McLintock MRCVS, companion animal business unit manager at Ceva Animal Health, said: "The launch of Milbactor and The Ceva Protection System will enable veterinary surgeons to offer their clients a simple regime featuring Vectra 3D and Milbactor for comprehensive parasite control in dogs. Offering protection both inside and out and with no bite required to kill fleas, the regime offers a simple, effective combination to treat and prevent fleas, ticks, biting flies, roundworms, tapeworms, lungworms and to prevent heartworm.
For further information on The Ceva Protection System, Milbactor, Vectra 3D or Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
As part of the new arrangement, Battersea will give StreetVet operational and logistical support, including advice from its staff, clinical support, and kennel space for animals in urgent need of care.
Battersea also plans to work with StreetVet on a range of projects that will help the charity to reach more dogs in need. For example, providing advice and training to hostel staff to promote and facilitate hostels accepting dogs – creating more safe places to sleep for both dogs and their owners.
Battersea’s Deputy Chief Executive, Peter Laurie, said: "I’m excited at the prospect of Battersea and StreetVet coming together for a partnership that aligns both organisations’ strategic values. Both of us care deeply about the welfare of dogs, particularly those most in need. StreetVet relies almost entirely on the support of a growing network of volunteers, including members of the Battersea clinic team, and is a great example of a volunteer-led organisation delivering significant impact on a wide geographical scale. By working together, we can increase our collective impact and help more animals in need."
Sam Joseph MRCVS, a co-founder of StreetVet, said: "We are really excited about the official partnership between StreetVet and Battersea. As a small, growing charity, StreetVet will hugely benefit from the expertise, infrastructure and resources of one of the country's most loved and respected animal charities."
He added: "This partnership will help StreetVet continue to provide free, accessible veterinary care to those most in need, while further increasing the impact that Battersea has on the welfare of dogs and cats across the UK."
Photo: L-R Peter Laurie (Battersea), Jade Statt and Sam Joseph (StreetVet), Shaun Opperman (Battersea) and Blue the Staffie
The charity says it joins mounting evidence that brachycephalic cats, including most modern Persians or Exotic Shorthairs, are suffering from a number of health problems, including breathing problems, eye inflammation, skin infections and difficulty eating.
In the study, published open access in the journal PLOS ONE, cat owners were asked to complete a detailed health questionnaire and submit photographs of their cats so that researchers could measure the muzzle ratio and nose position ratio. 1000 valid questionnaires and 373 valid photographs were received.
The research confirmed that flatter-faced cats (of breeds such as the Persian or Exotic Shorthair), were more likely to have breathing problems and that the breathing difficulties were also associated with increased tear staining and a more sedentary lifestyle.
A previous paper, published in the Journal of Feline Medicine and Surgery (JFMS)2 showed how the skulls of brachycephalic cats are actually deformed, especially the nose and jaw.
The charity says that unfortunately, breeds of cat and dog with flat faces are becoming more and more popular, and extremes (of an already abnormal anatomy) can become instant internet celebrities. These breeds and individuals often have large or prominent eyes which are considered by some to be 'cute' because they are baby-like, and the flattened face often has an up-turned or down-turned mouth, which gives it a human or cartoon characteristic of smiling or scowling, such as Grumpy Cat.
Claire Bessant, Chief Executive of International Cat Care said: "It is very depressing to see the life which has been deliberately dealt to some breeds of cats because of a human desire to develop a certain look. I urge cat lovers to speak out and help others to understand that this is not something we should be doing to cats, and not something we should be tolerating.
"One of the best and most beautifully naturally designed animals – the cat – would not normally have any of these problems; we have created them through selective breeding.
"We should not be encouraging people to breed these cats by calling them 'cute', by being amused at their facial characteristics, or by the fact that they snore – rather we need to understand that this is human intervention that is wholly detrimental to the welfare of the cats and is simply cruel.
"International Cat Care takes an ethical view of all cat breeds and our website (http://icatcare.org/advice/cat-breeds) outlines the problems that exist for some breeds, including very flat-faced cats in the Persians and Exotic breeds. Our stance is that we should never deliberately breed cats for any feature or characteristic that impairs their welfare."
Andrea Tarr, Veterinary Prescriber’s founder and director said: "There is a lot of confusion about the various rules and regulations around medicine storage. This module makes sense of it all. It is an essential read for anyone who deals with veterinary medicines, particularly those preparing for a VMD or RCVS PSS medicines inspection."
Veterinary Prescriber’s reviews are presented as e-learning modules. All the modules are the result of a thorough literature search and collaboration between practising specialists, general practitioners and the publication's editorial team.
Veterinary Prescriber is supported by subscriptions which cost £9.95 per month (cancel anytime) for individuals or £25 per month (for a 12-month contract) for practices. The latter includes 12 months free access to https://cpd.veterinaryprescriber.org for your practice's vet nurses, vet receptionists and SQPs.
To subscribe visit: https://www.veterinaryprescriber.org/subscribe
For further information, contact: carlrussell@veterinaryprescriber.org telephone 07932 044904.
Kriptazen is supplied with a twist-adjustable and weight-graduated dosing pump which means farmers can administer a precise dose up to 60kg without having to calculate it in ml’s first. Virbac says this will help to reduce the risk of incorrect dosing and toxicity issues.
Virbac’s Technical Product Manager Rosie Naylor said: "We are delighted to bring Kriptazen to the market. The trusted active halofuginone, along with the innovative weight graduated dosing pump, provides practices with added peace of mind when it comes to treatment."
For more information, contact your Virbac Territory Manager.
Bayer Animal Health has announced that it will launch Seresto, a new POM-V collar for cats and dogs that kills fleas and repels and kills ticks for up to eight months, in March.
According to Bayer, Seresto is the first treatment to provide repellency against ticks in both cats and dogs, and represents the fruit of a multidisciplinary effort incorporating the company's research into insecticides, polymers and veterinary parasiticides. The end result is a polymer-based collar that transfers the active ingredients to the lipid layer, from where they are spread by the animal's neutral oils.
Bayer Animal Health group product manager, Caroline Braidwood, said: "Seresto is simple to use on both cats and dogs. And because it is long lasting, it offers pet owners an alternative to those struggling to maintain a monthly routine. Bayer believes in innovation and Seresto is an enhancement to our product portfolio that meets the needs and requirements of pet owners and vets alike in the treatment of ticks and fleas."
Seresto contains two active ingredients - imidacloprid for fast action against fleas and flumethrin, which repels and kills ticks.
Caroline added: "Thanks to Seresto's unique polymer structure the active ingredients are safely locked away in the collar's matrix, and are released directly from the collar surface into the lipid layer of the animal at just the dose needed, ensuring optimal protection is sustained for up to 8 months."
Bayer says that because of its repellent (anti-feeding) effect, Seresto reduces the risk of vector-borne disease transmission - a first for cats. The company also says that because the active ingredients are stored on the inside of the polymer, it doesn't matter if the pet is shampooed and the lipid layer stripped off - the active ingredients are quickly replenished by the collar.
Seresto is odour-free and has a safety release mechanism to prevent strangulation. It is available in three sizes, Seresto Cat for cats less than 8kgs, Seresto Small Dog for dogs up to 8kgs and Seresto Large Dogs, for dogs over 8kg.
For further information about Seresto, contact your Bayer territory manager or call 01635 563000.
The webinar, which is presented by equine internal medicine specialist David Rendle from Rainbow Equine Hospital, challenges some of the current perceptions of worm control in horses and explains why veterinary surgeons need to engage more with horse owners on the topic to ensure a sustainable approach to parasite control.
Supported by Virbac, maker of Equimax and Eraquell horse wormers, the webinar is free to BEVA members at http://www.ebeva.org/webinar74.
The Stablelab hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA), an acute phase protein produced by the liver that increases rapidly and dramatically in response to inflammation.
Zoetis says that by measuring SAA, vets can assess the severity of an infection more quickly, often before clinical symptoms start, and are able to monitor the horse’s response over the course of treatment.1
Zoetis vet Wendy Talbot said: “Zoetis is committed to providing vets and horse owners with the most effective health products to better predict, prevent, detect and treat equine disease.
“The Stablelab test kit enables convenient, off-site testing for quick and accurate detection of a reliable indicator of infection in horses.
“Point-of-care testing is one of the fastest-growing areas of diagnostics and this test is rapidly becoming a standard of care in equine practice. SAA testing will help vets to quickly determine an appropriate course of intervention, positively impacting case outcomes.”
For more information, visit: www.stablelab.com. To place an order, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 (option 3).
The most recent case of rabies in a bat in Great Britain was in July 2020 in Wimbourne, Dorset and there were four cases in 2019.
Like many wild animals, bats can carry a number of different pathogens, including European Bat Lyssaviruses (EBLVs) 1 and 2 – also referred to as bat rabies. The rabies virus is present in the saliva of infected bats and is usually spread to humans or other mammals by the bite of an infected bat. The virus may also enter the body via open wounds or mucous membranes.
The BSAVA says that whilst the risk of transmission to humans is considered low, those handling bats may be at an increased risk of contracting the disease and those who regularly handle bats should be vaccinated against rabies.
Those who are not vaccinated against the disease should assume that all bats are possible carriers of rabies. Individuals handling bats should wear gloves of a suitable thickness for the species of bat they are handling to avoid being bitten or scratched. Further information on how to safely contain and handle a bat can be found on the Bat Conservation Trust website.
In the event that an individual is bitten or scratched by a bat or exposed to bat saliva or nervous tissue in any other way, they should seek immediate medical advice. The contact area should be washed with soap and water, and any wounds must be disinfected. Further information can be found on the APHA, PHE and NHS websites.
In 2008, a case involving an injured bat carrying EBLV type 2 was treated by a vet and her staff, who were unaware of the potential of rabies risk from bats. The bat handlers had previously been vaccinated as recommended by the Department of Health but despite sustaining a needlestick injury during surgery, the vet and her staff had neither sought nor received post-exposure prophylaxis.1
Professor Ian Ramsey, president of the BSAVA, said: “Although this case was 12 years ago it is a pertinent reminder of why we need to be well-prepared when handling bats. Whilst the risk of human rabies infection from bats is low, the publication of the new statistics show that EBLVs are circulating in a small number of wild bats. Injured bats are often presented to small animal vets, so we have taken this opportunity to remind our members and others of the potential risks of rabies transmission, and how to mitigate against these.
"For more advice on the handling and treatment of wildlife casualties including bats, we advise vets to consult a reference book such as the BSAVA Manual of Wildlife Casualties."
Bayer Animal Health has launched Remend Wound Spray Gel for cats, dogs and horses.
The new gel contains Remend's structurally modified hyaluronic acid (HA). Bayer says it provides a matrix for cellular events that occur during the proliferative phase of the healing process, which has been shown to enhance healing1, and can promote rapid wound closure
Georgie Hollis BSc from www.vetwoundlibrary.com said: "Managing wounds can be challenging in veterinary practice; the progression of wound healing can be influenced by many factors, and selecting an appropriate product to apply should be based on the needs of the individual wound. A product that provides a moist healing environment and support of the proliferative phase ensures that cellular activity is optimised, helping to improve healing times and minimise scar tissue."
Bayer says Remend Wound Spray Gel is designed for use as part of the overall management of wounds; additional measures such as lavage, debridement and control of infection are equally important, as is giving consideration to any secondary factors that may delay healing if not addressed. The product aims to achieve greater compliance amongst owners by providing an effective management option that is easy to apply. A single application may be sufficient to enhance wound closure in fresh uncomplicated wounds; however more complex wounds may require multiple applications in order to accelerate closure.
For more information, visit: www.vetcentre.bayer.co.uk
RCVS CEO Lizzie Lockett said: "I am so proud of our performance in the Great Place to Work Awards and the efforts of everyone at the College, and especially our HR team, who have been tirelessly and creatively striving to make the College a wonderful place to work.
"Consistently being placed in the top 50 Great Places to Work is also a testament to the sustained hard work all of our employees and the important part they play in creating a supportive, interesting and good-humoured workplace.
"We are a service-led organisation and we want to make sure that we give our best to the veterinary professions and the general public. If our team enjoys the work, and the workplace, that will improve the service we are able to offer and, ultimately, benefit animal health and welfare."
In 2009, Chiara (pictured right) was the first to be awarded by examination the title of European Veterinary Specialist in Oncology after completing a one-year small animal internship at the University of Glasgow and a three-year residency in internal medicine and oncology at the University of Edinburgh.
Alongside her clinical work, Chiara is an honorary lecturer at the University of Liverpool and a multi-lingual specialist consultant, writer and lecturer at events in the UK and Europe. Her focus is on postgraduate training in small animal oncology and internal medicine and online education of pet owners and animal carers. Chiara is a member of the general and oncology examination committees of the European College of Veterinary Internal Medicine (ECVIM).
She said: "My aim is to provide veterinarians and owners on a daily basis with the most up-to-date information on cancer diagnosis and treatment options so pets can spend more time with their families whilst protecting their quality of life and preventing suffering."
Samuela is a European Specialist in Veterinary Ophthalmology with a special interest in ocular pathology as well as corneal disease and surgery.
She said: "Working at Willows allows me to be part of a talented and passionate team, and a chance to become the best ophthalmologist I can. Willows offers a very high level of patient care, and working here gives me the opportunity for constant scientific and clinical development."
The BSAVA says there has been a real resurgence in the number of people keeping backyard poultry for a self-sufficient supply of food and because they often become part of the family, owners have come to expect a standard of veterinary care akin to that available for their cat or dog. Yet many veterinary surgeons are unfamiliar with consulting on and treating these birds.
The BSAVA Manual of Backyard Poultry Medicine and Surgery has been written by an international selection of specialist authors. It covers everything from husbandry and basic clinical techniques to medical and surgical treatment of conditions, and more advanced practices such as endoscopy and post-mortem examination.
The manual covers chickens, turkeys, ducks, geese, guinea fowl, ornamental pheasants and peafowl. The BSAVA says it is hoped that the manual will make treating backyard poultry more interesting and rewarding, and therefore encourage more practitioners to see feathered patients.
One of the editors, Guy Poland said: "We are very proud of the valuable contributions made by all the authors to the manual. We hope that their hard work will provide a useful resource for veterinary practitioners unfamiliar with poultry medicine to deliver improved care for their patients and maybe inspire an interest that they develop further."
BSAVA Manual of Backyard Poultry Medicine and Surgery is available in a printed edition (£85; £55 to BSAVA members) and online edition (£70.83+VAT; £45.83+VAT to BSAVA members).
The toolkit has been developed in conjunction with the RSPCA and includes a welfare workflow, quick download guides and welfare case forms. It can be downloaded here .
Merry Smith, a BEVA council member who led the project on behalf of BEVA, said: "Welfare assessments can sometimes be intimidating and it’s natural to feel vulnerable, particularly when circumstances are difficult. Our new Welfare Case Toolkit gives you access to the information and resources, even when you are on the road, to support you in dealing with a welfare case."
The interactive Welfare Workflow provides a step-by-step guide to what happens when a vet is called upon to provide an opinion on the health and welfare of the animals involved. It has been produced in a mobile-friendly format or can be printed out and kept in the car. Supporting the Workflow is a series of quick downloads, covering all aspects of the process:
Approach to the welfare case
Letter of instruction
Section 18 of the Animal Welfare Act (2006) certificate
Witness details sheet
Witness statement form
RSPCA vet exam form
Guidance notes on how to complete a vet exam welfare case form
Caroline Allen, Chief Veterinary Officer at the RSPCA said: "Vets are absolutely critical to the work of the RSPCA and while we know many vets get a lot of satisfaction from this work saving animals from cruelty and suffering, we know that this work can sometimes be daunting and the law confusing. We are delighted to have worked with BEVA on providing this guidance and hope it is the first step in us providing more support to vets doing this vital work- we literally couldn't do it without you"
The Welfare Case Toolkit is available free to BEVA members https://www.beva.org.uk/Resources-For-Vets-Practices/Clinical-Practice-Guidance/Welfare-guidance/Welfare-toolkit